On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
TEMPE, Ariz. (Sept. 8, 2022) — Marion Lanteri, Ph.D., began this week as Creative Testing Solu...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...